Cited 33 times in
The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김덕용 | - |
dc.contributor.author | 박은숙 | - |
dc.contributor.author | 박창일 | - |
dc.date.accessioned | 2016-05-16T11:21:36Z | - |
dc.date.available | 2016-05-16T11:21:36Z | - |
dc.date.issued | 2002 | - |
dc.identifier.issn | 0003-9993 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/144377 | - |
dc.description.abstract | Objective: To evaluate the changes in cortical somatosensory-evoked potentials (SEPs) after botulinum toxin type A injection to determine what effect spasticity has on cortical SEPs. Design: Intervention study and before-after trial. Setting: University-affiliated hospital in Korea. Participants: Twelve children with spastic hemiplegic cerebral palsy (CP), 7 children with spastic diplegic CP, and 8 patients with traumatic brain injury. Intervention: All participants had botulinum toxin type A injected into the muscles of the spastic limb. Main Outcome Measures: SEPs were recorded before and 7 days after the botulinum toxin type A injection. Spasticity of the affected spastic limb was also measured. The short latency and amplitude of waves in SEPs were measured. The SEP results were divided into 3 groups: flat (no evoked potential), abnormal (evoked but delayed in latency), and normal (clear waveform with normal latency). Results: The normal response of cortical SEP increased after injection. The SEPs exhibited more frequent improvement in the limbs, with greater improvement of spasticity in grade (>1.0 grade) and in patients of younger age (<3y) after injection (P<.05). Conclusion: The observed improvement of cortical SEPs with associated reduction of spasticity that occurred after the botulinum toxin type A injection indicates that spasticity itself can be considered a factor affecting cortical SEPs. © 2002 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1592~1596 | - |
dc.relation.isPartOf | ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Age Factors | - |
dc.subject.MESH | Botulinum Toxins, Type A/pharmacology | - |
dc.subject.MESH | Botulinum Toxins, Type A/therapeutic use* | - |
dc.subject.MESH | Brain Injuries/complications* | - |
dc.subject.MESH | Cerebral Palsy/complications* | - |
dc.subject.MESH | Child | - |
dc.subject.MESH | Child, Preschool | - |
dc.subject.MESH | Electric Stimulation | - |
dc.subject.MESH | Evoked Potentials, Somatosensory/drug effects* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Hemiplegia/complications* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Infant | - |
dc.subject.MESH | Injections, Intramuscular | - |
dc.subject.MESH | Magnetic Resonance Imaging | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Muscle Spasticity/classification | - |
dc.subject.MESH | Muscle Spasticity/diagnosis | - |
dc.subject.MESH | Muscle Spasticity/drug therapy* | - |
dc.subject.MESH | Muscle Spasticity/etiology | - |
dc.subject.MESH | Neuromuscular Agents/pharmacology | - |
dc.subject.MESH | Neuromuscular Agents/therapeutic use* | - |
dc.subject.MESH | Reaction Time/drug effects | - |
dc.subject.MESH | Severity of Illness Index | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Rehabilitation Medicine (재활의학) | - |
dc.contributor.googleauthor | Eun Sook Park | - |
dc.contributor.googleauthor | Chang Il Park | - |
dc.contributor.googleauthor | Deog Young Kim | - |
dc.contributor.googleauthor | Yong Rae Kim | - |
dc.identifier.doi | 10.1053/apmr.2002.34623 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00375 | - |
dc.contributor.localId | A01611 | - |
dc.contributor.localId | A01717 | - |
dc.relation.journalcode | J00230 | - |
dc.identifier.eissn | 1532-821X | - |
dc.identifier.pmid | 12422331 | - |
dc.identifier.url | http://www.archives-pmr.org/article/S0003-9993(02)00257-5/abstract | - |
dc.subject.keyword | Botulinum toxin type A | - |
dc.subject.keyword | Cerebral palsy | - |
dc.subject.keyword | Evoked potentials | - |
dc.subject.keyword | somatosensory | - |
dc.subject.keyword | Rehabilitation | - |
dc.subject.keyword | Spasticity | - |
dc.contributor.alternativeName | Kim, Deog Young | - |
dc.contributor.alternativeName | Park, Eun Sook | - |
dc.contributor.alternativeName | Park, Chang Il | - |
dc.contributor.affiliatedAuthor | Kim, Deog Young | - |
dc.contributor.affiliatedAuthor | Park, Eun Sook | - |
dc.contributor.affiliatedAuthor | Park, Chang Il | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 83 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1592 | - |
dc.citation.endPage | 1596 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, Vol.83(11) : 1592-1596, 2002 | - |
dc.identifier.rimsid | 49661 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.